CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Xbiotech Inc.  (XBIT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Xbiotech's Leverage Ratio

XBIT's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

XBIT Leverage Ratio (Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Equity Change -42.68 % -37.21 % -33.21 % - -
Y / Y Total Liabilities Change 24.2 % 34.06 % 262.01 % - -
Leverage Ratio MRQ 0.14 0.09 0.13 0.07 0.06
Overall Ranking # 260 # 160 # 256 # 142 # 143
Seq. Equity Change -17.54 % -13.5 % -12.54 % -8.12 % -9.67 %
Seq. Total Liabilities Change 19.86 % -35.91 % 57.94 % 2.38 % 29.38 %



Leverage Ratio forth quarter 2016 Comment
Due to net new borrowings of 19.86%, Leverage Ratio detoriated to 0.14, a new company high.

Within Major Pharmaceutical Preparations industry in the forth quarter 2016, 47 other companies have achieved lower Leverage Ratio than Xbiotech. While Leverage Ratio total ranking has deteriorated compare to previous quarter from 160 to 260.

Explain Leverage Ratio?
Who are XBIT Customers?
Leverage Ratio forth quarter 2016 Company Ranking
Within: No.
Industry # 48
Sector # 98
S&P 500 # 260


Leverage Ratio Statistics
High Average Low
0.14 0.08 0.02
(Dec 31 2016)   (Jun 30 2015)


You need to upgrade your Flash Player


Financial Statements
Xbiotech's Equity $ 59 Millions Visit XBIT's Balance sheet
Xbiotech's Total Liabilities $ 8 Millions Visit XBIT's Balance sheet
Source of XBIT's Sales Visit XBIT's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingDec 31 2016, within Major Pharmaceutical Preparations Industry Leverage RatioDec 31 2016 MRQ Total LiabilitiesDec 31 2016 MRQ Equity
Arqule Inc  0.37 $ 8.700  Millions$ 23.680  Millions
Galectin Therapeutics Inc  0.37 $ 3.780  Millions$ 10.292  Millions
Bellicum Pharmaceuticals, Inc.  0.37 $ 35.463  Millions$ 96.574  Millions
Xencor Inc  0.36 $ 114.544  Millions$ 313.954  Millions
Versartis, Inc.  0.36 $ 54.503  Millions$ 151.067  Millions
Arbutus Biopharma Corp  0.36 $ 72.914  Millions$ 203.005  Millions
China Pharma Holdings, Inc.  0.33 $ 19.611  Millions$ 58.909  Millions
Blueprint Medicines Corp  0.31 $ 66.925  Millions$ 213.078  Millions
Mirati Therapeutics, Inc.  0.31 $ 15.135  Millions$ 48.309  Millions
Newlink Genetics Corp  0.30 $ 39.281  Millions$ 129.466  Millions
Cempra, Inc.  0.30 $ 55.167  Millions$ 183.348  Millions
Amphastar Pharmaceuticals, Inc.  0.30 $ 98.483  Millions$ 329.255  Millions
Catabasis Pharmaceuticals Inc  0.30 $ 8.644  Millions$ 29.086  Millions
Pfenex Inc.  0.29 $ 22.977  Millions$ 80.145  Millions
Cumberland Pharmaceuticals Inc  0.28 $ 20.156  Millions$ 73.121  Millions
Dermira, Inc.  0.26 $ 65.231  Millions$ 247.370  Millions
Sarepta Therapeutics, Inc.  0.26 $ 87.413  Millions$ 336.691  Millions
Minerva Neurosciences, Inc.  0.25 $ 26.961  Millions$ 105.982  Millions
Antriabio, Inc.  0.25 $ 2.006  Millions$ 7.933  Millions
Epizyme, Inc.  0.25 $ 50.741  Millions$ 201.700  Millions
Actinium Pharmaceuticals, Inc.  0.25 $ 4.521  Millions$ 18.008  Millions
Dicerna Pharmaceuticals Inc  0.24 $ 10.044  Millions$ 41.208  Millions
Opko Health, Inc.  0.24 $ 509.480  Millions$ 2,091.808  Millions
Zynerba Pharmaceuticals, Inc.  0.24 $ 6.967  Millions$ 29.587  Millions
Rxi Pharmaceuticals Corp  0.23 $ 2.542  Millions$ 10.855  Millions
Cormedix Inc.  0.23 $ 4.092  Millions$ 17.815  Millions
Reliv International Inc  0.22 $ 3.317  Millions$ 14.914  Millions
Threshold Pharmaceuticals Inc  0.22 $ 4.395  Millions$ 19.888  Millions
Flexion Therapeutics Inc  0.21 $ 39.230  Millions$ 187.032  Millions
Rexahn Pharmaceuticals, Inc.  0.21 $ 3.535  Millions$ 17.058  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
TODEX's Profile
Stock Price
TODEX's Financials
TODEX's Expectations
Business Description
Fundamentals
Charts & Quotes
TODEX's News
Suppliers
TODEX's Competitors
Customers & Markets
Economic Indicators
TODEX's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com